molecules transparent


Sponsorship info

The AMP Europe Congress will bring together a network of molecular professionals and representatives of the diagnostics industry to educate healthcare practitioners and to advance the value of molecular laboratories in providing high quality patient care around the world. This multi-disciplinary scientific program will showcase molecular diagnostics with clinical applications in oncology (solid tumors, hematopathology), genetics (congenital, heritable), infectious diseases and informatics.
Be part of the AMP Europe Congress and gain maximum visibility as a sponsor. Please contact us to learn more about our sponsoring opportunities and to receive a sponsorship prospectus free of charge.

300+ Attendees

8 Industry sessions

Scientific Program



MedTech Compliant

We are thrilled to announce that the AMP Europe Congress 2024 application with MedTech
has been successful and the congress in Madrid is Compliant.

Learn more:

Confirmed Sponsors

Get in touch

If you are interested in sponsoring opportunities, please do not hesitate to contact us.

Alina Iakupova
Project Manager Industry Liaison

Federico Monzon

Federico A. Monzon is a molecular pathologist with extensive experience translating novel genomic technologies into clinical molecular tests, including leading studies on prostate and renal cancer genomics and the validation of one of the first FDA-cleared gene expression clinical assays for the diagnosis of tumors of unknown origin while at the University of Pittsburgh and Houston Methodist Hospital. At Invitae and Baylor Genetics laboratories, he pioneered the use of panel testing for hereditary cancers as well as cancer exome sequencing.

Dr. Monzon is a consultant on medical and scientific strategy for companies in the diagnostic space. Currently, he is Chief Medical Officer (CMO) at Delphi Diagnostics, a laboratory focused on providing genomic tools for the management of breast cancer patients. Prior to that, he served as CMP for Castle Diagnostics and served as Medical Director of Oncology and Medical Director for Latin America at Invitae Corporation. Previously, Dr. Monzon served as Director of Pathology at the Cancer Genetics Laboratory at Baylor College of Medicine. He earned his M.D. from the Universidad Nacional Autónoma de México (UNAM) and is board-certified by the American Board of Pathology in anatomic, clinical and molecular genetic pathology. Dr Monzon was the 2017 President of the Association for Molecular Pathology (AMP) and continues to be engaged in AMP and other professional societies to shape the future of clinical genomic medicine.